United States · FDA National Drug Code directory
Polymyxin B
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70594-049_809129ce-b9ab-4ff4-b2c2-6a0cac11a2bf
- Product NDC
- 70594-049
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- Polymyxin B Sulfate
- Labeler
- Xellia Pharmaceuticals USA LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20181001
- Source listing expiry
- 20271231
Source-listed ingredients
- POLYMYXIN B SULFATE — 500000 [USP'U]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (70594-049-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS · 70594-049-01
- 10 VIAL, GLASS in 1 CARTON (70594-049-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS · 70594-049-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →